C-cell hyperplasia of the thyroid
C-cell hyperplasia of the thyroid is rated under 38 CFR 38 CFR § 4.119, Diagnostic Code 7919, from 0% to 0% based on the frequency and functional severity of symptoms. The maximum 0% rating requires: If antineoplastic therapy is required, evaluate as a malignant neoplasm under DC 7914. If a prophylactic thyroidectomy is performed (based upon genetic testing) and antineoplastic therapy is not required, evaluate as hypothyroidism under DC 7903.. Most claims establish the 0% or 0% rating before reaching the top tier.
What are the VA rating criteria for C-cell hyperplasia of the thyroid?
If antineoplastic therapy is required, evaluate as a malignant neoplasm under DC 7914. If a prophylactic thyroidectomy is performed (based upon genetic testing) and antineoplastic therapy is not required, evaluate as hypothyroidism under DC 7903.
Note: Cross-reference — see referenced criteria for rating tiers
“If antineoplastic therapy is required, evaluate as a malignant neoplasm under DC 7914. If a prophylactic thyroidectomy is performed (based upon genetic testing) and antineoplastic therapy is not required, evaluate as hypothyroidism under DC 7903.”
Common Questions About C-cell hyperplasia of the thyroid VA Ratings
What is the VA rating range for C-cell hyperplasia of the thyroid?
The VA rates C-cell hyperplasia of the thyroid under Diagnostic Code 7919 at 0%. The minimum 0% rating requires: If antineoplastic therapy is required, evaluate as a malignant neoplasm under DC 7914. If a prophylactic thyroidectomy is performed (based upon genetic testing) and antineoplastic therapy is not required, evaluate as hypothyroidism under DC 7903.. The maximum 0% rating requires: If antineoplastic therapy is required, evaluate as a malignant neoplasm under DC 7914. If a prophylactic thyroidectomy is performed (based upon genetic testing) and antineoplastic therapy is not required, evaluate as hypothyroidism under DC 7903..
Which 38 CFR diagnostic code does the VA use for C-cell hyperplasia of the thyroid?
The VA rates C-cell hyperplasia of the thyroid under Diagnostic Code (DC) 7919, governed by 38 CFR 38 CFR § 4.119. The diagnostic code establishes the specific rating tiers and severity criteria the VA examiner applies.
Can C-cell hyperplasia of the thyroid qualify for TDIU (Total Disability Individual Unemployability)?
Veterans rated for C-cell hyperplasia of the thyroid may qualify for TDIU if the condition — alone or in combination with other service-connected disabilities — prevents substantially gainful employment. A single disability rated at 60% or higher (or multiple disabilities combining to 70%, with one at 40%) can support a TDIU claim under 38 CFR § 4.16.
What evidence do I need to establish service connection for C-cell hyperplasia of the thyroid?
Service connection for C-cell hyperplasia of the thyroid requires three elements: (1) a current diagnosis of the condition, (2) an in-service event, injury, or disease, and (3) a medical nexus linking the current diagnosis to that in-service occurrence. A nexus letter from a treating or independent medical examiner is the most reliable nexus evidence.
What is the C&P exam like for C-cell hyperplasia of the thyroid?
A Compensation & Pension (C&P) exam for C-cell hyperplasia of the thyroid uses a Disability Benefits Questionnaire (DBQ) specific to the body system involved. The examiner documents the frequency, severity, and functional impact of your symptoms. Bring all relevant treatment records and be prepared to describe your worst-day symptoms — the examiner rates your condition based on the full clinical picture, not a single visit.
Get a Personalized Rating Analysis
VeteranHQ evaluates your symptoms against the exact 38 CFR criteria, identifies secondary conditions, and shows what evidence you need to support a higher rating.
Discover Your Benefits